Exome sequencing in dementia with Lewy bodies

[1]  K. Itoh,et al.  p62 Deficiency Enhances α‐Synuclein Pathology in Mice , 2015, Brain pathology.

[2]  G. Frisoni,et al.  Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study , 2015, Neurobiology of Aging.

[3]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[4]  Michelle K. Lupton,et al.  Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease , 2014, Neurobiology of Aging.

[5]  W. M. van der Flier,et al.  Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies , 2014, Human molecular genetics.

[6]  D. G. MacArthur,et al.  Guidelines for investigating causality of sequence variants in human disease , 2014, Nature.

[7]  J. Hardy,et al.  SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. , 2013, JAMA neurology.

[8]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[9]  A. Kakita,et al.  Endosomal sorting related protein CHMP2B is localized in Lewy bodies and glial cytoplasmic inclusions in α-synucleinopathy , 2012, Neuroscience Letters.

[10]  S. Ajroud‐Driss,et al.  SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. , 2011, Archives of neurology.

[11]  R. Mayeux,et al.  Familial aggregation of dementia with Lewy bodies. , 2011, Archives of neurology.

[12]  K. Marder,et al.  Association of glucocerebrosidase mutations with dementia with lewy bodies. , 2009, Archives of neurology.

[13]  Andrew King,et al.  Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium , 2009, Acta Neuropathologica.

[14]  C. Morris,et al.  BuChE‐K and APOE ϵ4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline , 2009, Movement disorders : official journal of the Movement Disorder Society.

[15]  A. Singleton,et al.  Lack of replication of association between GIGYF2 variants and Parkinson disease. , 2008, Human molecular genetics.

[16]  J. Burgunder,et al.  LRRK2 Gly2385Arg variant is a risk factor of Parkinson’s disease among Han‐Chinese from mainland China , 2008, European journal of neurology.

[17]  E. Londos,et al.  Patients with Lewy body dementia use more resources than those with Alzheimer's disease , 2007, International journal of geriatric psychiatry.

[18]  J. Collinge,et al.  ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B) , 2006, Neurology.

[19]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[20]  G. Schellenberg,et al.  Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype. , 2006, Archives of neurology.

[21]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[22]  D. Duffy,et al.  Identification of families with cortical Lewy body disease , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[23]  O. Wiestler,et al.  Vascular Pathology in Alzheimer Disease: Correlation of Cerebral Amyloid Angiopathy and Arteriosclerosis/Lipohyalinosis with Cognitive Decline , 2003, Journal of neuropathology and experimental neurology.

[24]  R. Sulkava,et al.  Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older , 2003, Journal of neurology, neurosurgery, and psychiatry.

[25]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[26]  P. Pástor,et al.  A novel presenilin 2 gene mutation (D439A) in a patient with early-onset Alzheimer’s disease , 2001, Neurology.

[27]  Istvan Bodi,et al.  Staging/typing of Lewy body related alpha-synuclein pathology , 2016 .